Levetiracetam 500 mg is a common dosage for the oral tablet form of levetiracetam, an antiepileptic medication used to treat seizures [1]. It is available in various strengths, including 250 mg, 500 mg, 750 mg, and 1000 mg [1].
How is Levetiracetam 500mg typically prescribed?
Levetiracetam 500 mg can be prescribed as a starting dose for adults and children aged 12 years and older experiencing partial-onset seizures, myoclonic seizures, or primary generalized tonic-clonic seizures [1]. Dosing often begins at 500 mg twice daily and may be increased to a maximum of 1500 mg twice daily, depending on the individual's response and tolerance [1]. For children younger than 12 years, the dose is typically based on weight [1].
What conditions does Levetiracetam treat?
Levetiracetam is indicated for the treatment of seizures associated with epilepsy [1]. This includes partial-onset seizures, myoclonic seizures in patients with juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures in patients with epilepsy [1].
How quickly does Levetiracetam 500mg start working?
Levetiracetam is generally absorbed rapidly after oral administration. Peak plasma concentrations are typically reached within 1 to 2 hours [1]. While individual responses vary, therapeutic effects can begin to be observed as the drug reaches consistent therapeutic levels in the bloodstream [1].
When does the patent for levetiracetam expire?
Levetiracetam, originally marketed as Keppra, is an older drug. The primary patents for the original formulation have long since expired, allowing for the widespread availability of generic versions [2]. Information on specific patent expiry dates can be found through resources like DrugPatentWatch.com [2].
Are there generic versions of Levetiracetam 500mg available?
Yes, due to patent expirations, numerous generic versions of levetiracetam are available. These generics offer the same active ingredient and therapeutic effects as the brand-name drug but are typically more affordable [2].
What are the potential side effects of Levetiracetam 500mg?
Common side effects of levetiracetam can include somnolence, asthenia (weakness), dizziness, and behavioral abnormalities such as aggression, agitation, anxiety, and depression [1]. It is important for patients to discuss any side effects with their healthcare provider [1].
Can Levetiracetam 500mg be taken with other medications?
Levetiracetam has a relatively low potential for drug interactions compared to some other antiepileptic drugs. However, it is crucial for patients to inform their doctor about all other medications, including over-the-counter drugs and herbal supplements, they are taking to avoid any potential interactions [1].
What is the difference between levetiracetam and other seizure medications?
Levetiracetam is considered a third-generation antiepileptic drug. It works by binding to synaptic vesicle protein 2A (SV2A), which is believed to modulate the release of neurotransmitters [1]. Unlike some older antiepileptic drugs, levetiracetam has a different mechanism of action and a generally more favorable drug interaction profile [1].
Who manufactures Levetiracetam?
Both the original brand-name drug (Keppra) and numerous generic versions of levetiracetam are manufactured by various pharmaceutical companies worldwide [2]. The availability of generics means that many different manufacturers produce levetiracetam 500 mg tablets.
Where can I find more information on levetiracetam patents?
Detailed information on the patent landscape for levetiracetam, including expiry dates and any associated litigation, can be accessed through specialized patent databases and resources such as DrugPatentWatch.com [2].
What are the patient concerns regarding Levetiracetam 500mg?
Patient concerns often revolve around potential side effects like drowsiness, mood changes, and behavioral issues. Adherence to prescribed dosages and open communication with healthcare providers about any experienced side effects are key to managing these concerns [1].
---
Sources:
1. https://www.drugs.com/levetiracetam.html
2. https://drugpatentwatch.com/